
The Battle to Make Drugs as Pure and Stable as Possible: Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them
Brief intro:
- Author: Mike May
- Journal: Genetic Engineering & Biotechnology News
- Doi: https://www.doi.org/10.1089/gen.45.09.16
- Publication Date: 2025/9/9
About PackGene
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.
